V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10462734 | 10035066 | 1.7 | null | null | 2020-10-12 | 2020-10-12 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100482586 |
| 10462739 | 10035067 | 1.55 | 90.2 | Adjuvant (A) | 2017-02-21 | 2017-02-27 | Rituximab (Maintenance) | N | N | RITUXIMAB | 100593915 |
| 10462742 | 10035068 | null | 93 | Palliative (P) | 2015-09-16 | 2015-09-29 | Capecitabine + Oxaliplatin 21day | N | N | IBRUTINIB | 100559470 |
| 10462753 | 10035069 | 1.8 | 78.4 | Palliative (P) | 2020-01-07 | 2020-01-07 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100459884 |
| 10462807 | 10035071 | 1.79 | 75 | Palliative (P) | 2021-05-05 | 2021-05-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101565491 |
| 10462829 | 10035072 | 1.74 | 73.8 | Palliative (P) | 2017-08-26 | 2019-10-18 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | RITUXIMAB | 101467780 |
| 10462838 | 10035073 | 1.7 | 81.8 | 03 | 2018-04-04 | 2018-04-04 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101499846 |
| 10462839 | 10035074 | 1.77 | 84.4 | Palliative (P) | 2016-11-13 | 2016-11-13 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 101364522 |
| 10462880 | 10035075 | 1.84 | 94 | Palliative (P) | 2017-11-18 | 2017-12-05 | Capecitabine | 02 | N | CAPECITABINE | 100389529 |
| 10462892 | 10035076 | 1.75 | 59.6 | Adjuvant (A) | 2021-05-12 | 2021-06-06 | Docetaxel | 02 | null | DOCETAXEL | 101166779 |
| 10462912 | 10035077 | 1.84 | 103 | null | 2021-09-06 | 2021-09-16 | Capecitabine | 02 | null | CAPECITABINE | 100375105 |
| 10462930 | 10035078 | 1.55 | 101 | Curative (C) | 2017-04-07 | 2017-04-13 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101839023 |
| 10462935 | 10035079 | 1.55 | 91.6 | Palliative (P) | 2021-07-05 | 2021-07-09 | Rituximab | 02 | null | RITUXIMAB | 101476857 |
| 10462938 | 10035080 | 1.79 | 98.1 | Disease modification (D) | 2017-08-07 | 2017-08-14 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101314729 |
| 10462940 | 10035081 | 1.67 | 91.3 | null | 2022-02-19 | 2022-03-05 | Rituximab | 02 | null | RITUXIMAB | 101288344 |
| 10462959 | 10035082 | 1.63 | 50 | 03 | 2018-03-21 | 2018-03-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101590797 |
| 10462968 | 10035083 | 1.69 | 59.7 | Disease modification (D) | 2015-10-09 | 2015-10-18 | CAPECITABINE + OXALIPLATIN | N | N | PEMBROLIZUMAB | 100176971 |
| 10462978 | 10035084 | 1.67 | null | 03 | 2016-11-23 | 2016-11-29 | IBRUTINIB | 2 | N | IBRUTINIB | 101759109 |
| 10462993 | 10035085 | 1.7 | 67.25 | Curative (C) | 2019-02-24 | 2019-02-24 | Capecitabine | 02 | N | CAPECITABINE | 100607775 |
| 10462999 | 10035086 | 1.74 | 88.6 | Palliative (P) | 2017-07-29 | 2017-08-27 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101760852 |
| 10463004 | 10035087 | 1.72 | 50.35 | Palliative (P) | 2016-11-18 | 2016-11-25 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100246272 |
| 10463015 | 10035088 | 1.69 | 73 | Neo-adjuvant (N) | 2017-08-25 | 2017-09-26 | IBRUTINIB | 02 | N | IBRUTINIB | 100738121 |
| 10463030 | 10035089 | 1.76 | 80.5 | Adjuvant (A) | 2021-03-07 | 2021-03-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100462080 |
| 10463100 | 10035090 | 1.76 | 69.1 | Palliative (P) | 2015-12-22 | 2015-12-22 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 100575757 |
| 10463114 | 10035091 | 1.85 | 83.4 | Curative (C) | 2020-02-12 | 2020-03-04 | Docetaxel | 02 | null | DOCETAXEL | 100834043 |
| 10463118 | 10035092 | 1.93 | 69.7 | Palliative (P) | 2019-02-27 | 2019-03-26 | Docetaxel | 02 | N | DOCETAXEL | 101800703 |
| 10463147 | 10035093 | 1.82 | 62.5 | Adjuvant (A) | 2018-09-29 | 2018-10-13 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100061383 |
| 10463149 | 10035094 | 1.76 | 69.8 | 02 | 2016-09-09 | 2016-09-13 | Docetaxel | N | N | DOCETAXEL | 101499761 |
| 10463162 | 10035095 | 1.82 | 83 | Palliative (P) | 2020-02-12 | 2020-03-09 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100305532 |
| 10463164 | 10035096 | 1.53 | 81.1 | null | 2020-11-03 | 2020-11-06 | Rituximab | 02 | null | RITUXIMAB | 101017854 |
| 10463179 | 10035097 | 1.76 | 84 | Adjuvant (A) | 2020-03-24 | 2020-03-24 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100500703 |
| 10463199 | 10035099 | 1.72 | 105.3 | Palliative (P) | 2018-01-12 | 2018-01-12 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100494032 |
| 10463202 | 10035100 | 1.89 | 50.5 | Neo-adjuvant (N) | 2018-02-07 | 2018-02-12 | Rituximab | 02 | N | RITUXIMAB | 100633248 |
| 10463215 | 10035101 | 1.66 | 95.4 | 03 | 2015-09-10 | 2015-09-10 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100632262 |
| 10463251 | 10035102 | 1.62 | 71 | Disease modification (D) | 2018-04-11 | 2018-05-05 | DOCETAXEL + Prednisolone | 02 | N | DOCETAXEL | 101386511 |
| 10463254 | 10035103 | 1.66 | 72 | 03 | 2017-10-16 | 2017-10-16 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100614576 |
| 10463270 | 10035104 | 1.74 | 97 | Disease modification (D) | 2016-04-11 | 2016-05-04 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100879331 |
| 10463278 | 10035105 | 1.76 | 81 | null | null | 2017-09-02 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 100685369 |
| 10463283 | 10035106 | 1.77 | 62.1 | null | 2021-07-24 | 2021-07-28 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101702299 |
| 10463310 | 10035107 | 1.81 | 101 | Palliative (P) | 2020-07-12 | 2020-08-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101700597 |
| 10463316 | 10035108 | null | 73.6 | null | 2017-01-05 | 2017-01-05 | IBRUTINIB | 02 | null | IBRUTINIB | 100616224 |
| 10463319 | 10035109 | 1.73 | 89.5 | null | 2019-11-10 | 2019-11-12 | IBRUTINIB | 02 | null | IBRUTINIB | 100515060 |
| 10463338 | 10035110 | 1.79 | 0 | Curative (C) | 2016-08-02 | 2016-08-03 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101711145 |
| 10463346 | 10035111 | 1.6 | 103.5 | Palliative (P) | 2017-12-06 | 2017-12-16 | Capecitabine | 02 | N | CAPECITABINE | 101598919 |
| 10463364 | 10035112 | 1.72 | 76.7 | Curative (C) | 2014-02-19 | 2014-03-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101294259 |
| 10463368 | 10035113 | 0 | 102.75 | Palliative (P) | 2019-11-24 | 2019-11-26 | IBRUTINIB | 02 | null | IBRUTINIB | 101721007 |
| 10463371 | 10035114 | 1.57 | 86.3 | Palliative (P) | 2017-06-26 | 2017-07-14 | Capecitabine + Oxaliplatin 21day | 99 | N | PEMBROLIZUMAB | 100038046 |
| 10463375 | 10035115 | 1.49 | 65.4 | null | 2011-12-26 | 2017-12-08 | Capecitabine | 02 | null | CAPECITABINE | 100023492 |
| 10463377 | 10035116 | null | null | Curative (C) | 2019-04-05 | 2019-04-08 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101262932 |
| 10463381 | 10035117 | 1.69 | null | Disease modification (D) | 2019-08-07 | 2019-08-07 | Capecitabine | 02 | N | CAPECITABINE | 100482145 |